Copyright Reports & Markets. All rights reserved.

Global Home and Alternate Site Infusion Therapy Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Home and Alternate Site Infusion Therapy Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Chemotherapy
    • 1.2.3 Anti-infective Therapies
    • 1.2.4 Immune Therapy
    • 1.2.5 General Nursing Services
    • 1.2.6 Others
  • 1.3 Market by Application
    • 1.3.1 Global Home and Alternate Site Infusion Therapy Market Share by Application: 2020 VS 2026
    • 1.3.2 Residential
    • 1.3.3 Ambulatory Infusion Centers
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Home and Alternate Site Infusion Therapy Market Perspective (2015-2026)
  • 2.2 Global Home and Alternate Site Infusion Therapy Growth Trends by Regions
    • 2.2.1 Home and Alternate Site Infusion Therapy Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Home and Alternate Site Infusion Therapy Historic Market Share by Regions (2015-2020)
    • 2.2.3 Home and Alternate Site Infusion Therapy Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Home and Alternate Site Infusion Therapy Players by Market Size
    • 3.1.1 Global Top Home and Alternate Site Infusion Therapy Players by Revenue (2015-2020)
    • 3.1.2 Global Home and Alternate Site Infusion Therapy Revenue Market Share by Players (2015-2020)
  • 3.2 Global Home and Alternate Site Infusion Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Home and Alternate Site Infusion Therapy Revenue
  • 3.4 Global Home and Alternate Site Infusion Therapy Market Concentration Ratio
    • 3.4.1 Global Home and Alternate Site Infusion Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Home and Alternate Site Infusion Therapy Revenue in 2019
  • 3.5 Key Players Home and Alternate Site Infusion Therapy Area Served
  • 3.6 Key Players Home and Alternate Site Infusion Therapy Product Solution and Service
  • 3.7 Date of Enter into Home and Alternate Site Infusion Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Home and Alternate Site Infusion Therapy Breakdown Data by Type (2015-2026)

  • 4.1 Global Home and Alternate Site Infusion Therapy Historic Market Size by Type (2015-2020)
  • 4.2 Global Home and Alternate Site Infusion Therapy Forecasted Market Size by Type (2021-2026)

5 Home and Alternate Site Infusion Therapy Breakdown Data by Application (2015-2026)

  • 5.1 Global Home and Alternate Site Infusion Therapy Historic Market Size by Application (2015-2020)
  • 5.2 Global Home and Alternate Site Infusion Therapy Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Home and Alternate Site Infusion Therapy Market Size (2015-2026)
  • 6.2 North America Home and Alternate Site Infusion Therapy Market Size by Type (2015-2020)
  • 6.3 North America Home and Alternate Site Infusion Therapy Market Size by Application (2015-2020)
  • 6.4 North America Home and Alternate Site Infusion Therapy Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Home and Alternate Site Infusion Therapy Market Size (2015-2026)
  • 7.2 Europe Home and Alternate Site Infusion Therapy Market Size by Type (2015-2020)
  • 7.3 Europe Home and Alternate Site Infusion Therapy Market Size by Application (2015-2020)
  • 7.4 Europe Home and Alternate Site Infusion Therapy Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Home and Alternate Site Infusion Therapy Market Size (2015-2026)
  • 8.2 China Home and Alternate Site Infusion Therapy Market Size by Type (2015-2020)
  • 8.3 China Home and Alternate Site Infusion Therapy Market Size by Application (2015-2020)
  • 8.4 China Home and Alternate Site Infusion Therapy Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Home and Alternate Site Infusion Therapy Market Size (2015-2026)
  • 9.2 Japan Home and Alternate Site Infusion Therapy Market Size by Type (2015-2020)
  • 9.3 Japan Home and Alternate Site Infusion Therapy Market Size by Application (2015-2020)
  • 9.4 Japan Home and Alternate Site Infusion Therapy Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Home and Alternate Site Infusion Therapy Market Size (2015-2026)
  • 10.2 Southeast Asia Home and Alternate Site Infusion Therapy Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Home and Alternate Site Infusion Therapy Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Home and Alternate Site Infusion Therapy Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 Option Care Health
    • 11.1.1 Option Care Health Company Details
    • 11.1.2 Option Care Health Business Overview
    • 11.1.3 Option Care Health Home and Alternate Site Infusion Therapy Introduction
    • 11.1.4 Option Care Health Revenue in Home and Alternate Site Infusion Therapy Business (2015-2020))
    • 11.1.5 Option Care Health Recent Development
  • 11.2 Coram CVS
    • 11.2.1 Coram CVS Company Details
    • 11.2.2 Coram CVS Business Overview
    • 11.2.3 Coram CVS Home and Alternate Site Infusion Therapy Introduction
    • 11.2.4 Coram CVS Revenue in Home and Alternate Site Infusion Therapy Business (2015-2020)
    • 11.2.5 Coram CVS Recent Development
  • 11.3 UnitedHealth Group
    • 11.3.1 UnitedHealth Group Company Details
    • 11.3.2 UnitedHealth Group Business Overview
    • 11.3.3 UnitedHealth Group Home and Alternate Site Infusion Therapy Introduction
    • 11.3.4 UnitedHealth Group Revenue in Home and Alternate Site Infusion Therapy Business (2015-2020)
    • 11.3.5 UnitedHealth Group Recent Development
  • 11.4 HCA Healthcare
    • 11.4.1 HCA Healthcare Company Details
    • 11.4.2 HCA Healthcare Business Overview
    • 11.4.3 HCA Healthcare Home and Alternate Site Infusion Therapy Introduction
    • 11.4.4 HCA Healthcare Revenue in Home and Alternate Site Infusion Therapy Business (2015-2020)
    • 11.4.5 HCA Healthcare Recent Development
  • 11.5 McLaren
    • 11.5.1 McLaren Company Details
    • 11.5.2 McLaren Business Overview
    • 11.5.3 McLaren Home and Alternate Site Infusion Therapy Introduction
    • 11.5.4 McLaren Revenue in Home and Alternate Site Infusion Therapy Business (2015-2020)
    • 11.5.5 McLaren Recent Development
  • 11.6 CHI Health
    • 11.6.1 CHI Health Company Details
    • 11.6.2 CHI Health Business Overview
    • 11.6.3 CHI Health Home and Alternate Site Infusion Therapy Introduction
    • 11.6.4 CHI Health Revenue in Home and Alternate Site Infusion Therapy Business (2015-2020)
    • 11.6.5 CHI Health Recent Development
  • 11.7 Accredo Health
    • 11.7.1 Accredo Health Company Details
    • 11.7.2 Accredo Health Business Overview
    • 11.7.3 Accredo Health Home and Alternate Site Infusion Therapy Introduction
    • 11.7.4 Accredo Health Revenue in Home and Alternate Site Infusion Therapy Business (2015-2020)
    • 11.7.5 Accredo Health Recent Development
  • 11.8 PharMerica
    • 11.8.1 PharMerica Company Details
    • 11.8.2 PharMerica Business Overview
    • 11.8.3 PharMerica Home and Alternate Site Infusion Therapy Introduction
    • 11.8.4 PharMerica Revenue in Home and Alternate Site Infusion Therapy Business (2015-2020)
    • 11.8.5 PharMerica Recent Development
  • 11.9 Cleveland Clinic
    • 11.9.1 Cleveland Clinic Company Details
    • 11.9.2 Cleveland Clinic Business Overview
    • 11.9.3 Cleveland Clinic Home and Alternate Site Infusion Therapy Introduction
    • 11.9.4 Cleveland Clinic Revenue in Home and Alternate Site Infusion Therapy Business (2015-2020)
    • 11.9.5 Cleveland Clinic Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Home and Alternate Site Infusion Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Home and Alternate Site Infusion Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Chemotherapy
    Anti-infective Therapies
    Immune Therapy
    General Nursing Services
    Others

    Market segment by Application, split into
    Residential
    Ambulatory Infusion Centers
    Others

    Based on regional and country-level analysis, the Home and Alternate Site Infusion Therapy market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Home and Alternate Site Infusion Therapy market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    Option Care Health
    Coram CVS
    UnitedHealth Group
    HCA Healthcare
    McLaren
    CHI Health
    Accredo Health
    PharMerica
    Buy now